Zaditen change of marketing authorisation
The marketing authorisation rights of Zaditen Syrup and Zaditen Tablets (ketotifen fumarate) in the UK has now been transferred from Sobi to CD Pharma. All product enquiries should now be addressed to CD Pharm. UDG remain the UK distributors. Further information on 01773 510123.
Citation: The Pharmaceutical Journal DOI: 10.1211/PJ.2014.20066711